tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RZLT Stock Latest News

Rezolute’s Strategic Advances in Rare Disease Therapies
Company AnnouncementsRezolute’s Strategic Advances in Rare Disease Therapies
17d ago
RZLT
Rezolute’s Promising Clinical Trials and Robust Financials Justify ‘Buy’ Rating
PremiumRatings
Rezolute’s Promising Clinical Trials and Robust Financials Justify ‘Buy’ Rating
18d ago
RZLT
Rezolute to announce DMC conclusions in April, says H.C. Wainwright
PremiumThe Fly
Rezolute to announce DMC conclusions in April, says H.C. Wainwright
19d ago
RZLT
Rezolute price target raised to $9 from $8 at JMP Securities
PremiumThe Fly
Rezolute price target raised to $9 from $8 at JMP Securities
19d ago
RZLT
Rezolute reports Q2 EPS (22c), consensus (26c)
PremiumThe Fly
Rezolute reports Q2 EPS (22c), consensus (26c)
20d ago
RZLT
Rezolute’s Advancements in CHI Treatment and Strategic Positioning Justify Buy Rating with $14 Target
PremiumRatingsRezolute’s Advancements in CHI Treatment and Strategic Positioning Justify Buy Rating with $14 Target
27d ago
RZLT
Promising Developments in Rezolute’s cHI Treatment Drive Buy Rating
Premium
Ratings
Promising Developments in Rezolute’s cHI Treatment Drive Buy Rating
27d ago
RZLT
Rezolute Advances SunRIZE Study for Hypoglycemia Treatment
Premium
Company Announcements
Rezolute Advances SunRIZE Study for Hypoglycemia Treatment
28d ago
8K
RZLT
Rezolute provides update on Phase 3 sunRIZE study on ersodetug
PremiumThe Fly
Rezolute provides update on Phase 3 sunRIZE study on ersodetug
28d ago
RZLT
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
29d ago
RZLT
Rezolute Highlights Promising Phase 2 Ersodetug Results
PremiumCompany Announcements
Rezolute Highlights Promising Phase 2 Ersodetug Results
2M ago
8K
RZLT
Rezolute Gains FDA Breakthrough Designation for Ersodetug
PremiumCompany Announcements
Rezolute Gains FDA Breakthrough Designation for Ersodetug
2M ago
8K
RZLT
Rezolute receives BTD from FDA for ersodetug in treatment of hypoglycemia
PremiumThe FlyRezolute receives BTD from FDA for ersodetug in treatment of hypoglycemia
2M ago
RZLT
Rezolute reports inducement award under Nasdaq listing rule
Premium
The Fly
Rezolute reports inducement award under Nasdaq listing rule
3M ago
RZLT
Rezolute announces U.S. FDA granted ODD to ersodetug
Premium
The Fly
Rezolute announces U.S. FDA granted ODD to ersodetug
3M ago
RZLT
Rezolute, Inc. Advances Late-Stage Trials for Rare Disease Therapies
PremiumCompany Announcements
Rezolute, Inc. Advances Late-Stage Trials for Rare Disease Therapies
3M ago
RZLT
Rezolute granted FDA orphan designation for treatment of hypoglycemia
PremiumThe Fly
Rezolute granted FDA orphan designation for treatment of hypoglycemia
3M ago
RZLT
Rezolute price target raised to $8 from $7 at JMP Securities
PremiumThe Fly
Rezolute price target raised to $8 from $7 at JMP Securities
4M ago
RZLT
Rezolute reports Q1 EPS (22c), consensus (33c)
PremiumThe Fly
Rezolute reports Q1 EPS (22c), consensus (33c)
4M ago
RZLT
RZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsRZLT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
RZLT
Rezolute initiated with an Outperform at Wedbush
Premium
The Fly
Rezolute initiated with an Outperform at Wedbush
4M ago
RZLT
Rezolute initiated with an Outperform at Wedbush
Premium
The Fly
Rezolute initiated with an Outperform at Wedbush
4M ago
RZLT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >